Glen Eagle Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $717K | Buy |
8,272
+432
| +6% | +$41.4K | 0.1% | 136 |
|
|
2025
Q4 | $753K | Sell |
7,840
-110
| -1% | -$10.7K | 0.1% | 135 |
|
|
2025
Q3 | $757K | Sell |
7,950
-5,928
| -43% | -$545K | 0.11% | 133 |
|
|
2025
Q2 | $1.21M | Buy |
13,878
+211
| +2% | +$17.9K | 0.19% | 89 |
|
|
2025
Q1 | $1.23M | Buy |
13,667
+5,991
| +78% | +$536K | 0.2% | 87 |
|
|
2024
Q4 | $613K | Sell |
7,676
-358
| -4% | -$31K | 0.1% | 129 |
|
|
2024
Q3 | $723K | Sell |
8,034
-34
| -0.4% | -$2.86K | 0.12% | 115 |
|
|
2024
Q2 | $635K | Buy |
8,068
+150
| +2% | +$12.3K | 0.12% | 119 |
|
|
2024
Q1 | $690K | Sell |
7,918
-109
| -1% | -$9.3K | 0.13% | 118 |
|
|
2023
Q4 | $661K | Sell |
8,027
-613
| -7% | -$46.7K | 0.14% | 119 |
|
|
2023
Q3 | $677K | Sell |
8,640
-125
| -1% | -$10.5K | 0.16% | 112 |
|
|
2023
Q2 | $772K | Sell |
8,765
-273
| -3% | -$23.5K | 0.18% | 100 |
|
|
2023
Q1 | $729K | Sell |
9,038
-2,509
| -22% | -$204K | 0.18% | 103 |
|
|
2022
Q4 | $897K | Sell |
11,547
-572
| -5% | -$46.4K | 0.25% | 86 |
|
|
2022
Q3 | $979K | Sell |
12,119
-586
| -5% | -$52.7K | 0.28% | 74 |
|
|
2022
Q2 | $1.14M | Buy |
12,705
+118
| +0.9% | +$12K | 0.31% | 68 |
|
|
2022
Q1 | $1.4M | Buy |
12,587
+945
| +8% | +$99.8K | 0.36% | 60 |
|
|
2021
Q4 | $1.2M | Sell |
11,642
-522
| -4% | -$60.4K | 0.31% | 73 |
|
|
2021
Q3 | $1.52M | Sell |
12,164
-162
| -1% | -$21K | 0.44% | 56 |
|
|
2021
Q2 | $1.53M | Buy |
12,326
+141
| +1% | +$17.7K | 0.48% | 52 |
|
|
2021
Q1 | $1.44M | Sell |
12,185
-542
| -4% | -$63.5K | 0.5% | 47 |
|
|
2020
Q4 | $1.49M | Sell |
12,727
-142
| -1% | -$15.6K | 0.59% | 42 |
|
|
2020
Q3 | $1.34M | Sell |
12,869
-228
| -2% | -$22.9K | 0.6% | 39 |
|
|
2020
Q2 | $1.2M | Buy |
13,097
+469
| +4% | +$45K | 0.62% | 39 |
|
|
2020
Q1 | $1.14M | Sell |
12,628
-2,509
| -17% | -$267K | 0.8% | 31 |
|
|
2019
Q4 | $1.72M | Buy |
15,137
+3,291
| +28% | +$361K | 0.92% | 24 |
|
|
2019
Q3 | $1.29M | Buy |
11,846
+280
| +2% | +$29.2K | 0.85% | 27 |
|
|
2019
Q2 | $1.13M | Sell |
11,566
-99
| -0.8% | -$9.04K | 0.77% | 28 |
|
|
2019
Q1 | $1.06M | Buy |
11,665
+370
| +3% | +$33.1K | 0.77% | 30 |
|
|
2018
Q4 | $1.03M | Buy |
11,295
+33
| +0.3% | +$3.08K | 0.87% | 26 |
|
|
2018
Q3 | $1.11M | Buy |
11,262
+457
| +4% | +$42.3K | 0.79% | 30 |
|
|
2018
Q2 | $925K | Buy |
10,805
+601
| +6% | +$50.2K | 0.73% | 33 |
|
|
2018
Q1 | $819K | Sell |
10,204
-180
| -2% | -$14.8K | 0.68% | 36 |
|
|
2017
Q4 | $838K | Buy |
10,384
+1,489
| +17% | +$119K | 0.73% | 33 |
|
|
2017
Q3 | $692K | Sell |
8,895
-3,936
| -31% | -$327K | 0.65% | 38 |
|
|
2017
Q2 | $1.14M | Buy |
12,831
+177
| +1% | +$14.9K | 0.91% | 24 |
|
|
2017
Q1 | $1.02M | Buy |
12,654
+811
| +7% | +$63.4K | 0.88% | 23 |
|
|
2016
Q4 | $844K | Buy |
+11,843
| New | +$930K | 0.76% | 25 |
|
Other funds holding MDT
VCM
VPM
Glen Eagle Advisors's MDT Position: Q1 2026 in Review
Glen Eagle Advisors increased its Medtronic (MDT) stake by 5.5% in Q1 2026, buying an estimated $41.4K and bringing the position to 8,272 shares worth $717K. The position accounts for 0.1% of the portfolio, ranked #136.
Glen Eagle Advisors first reported a position in MDT in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.72M in Q4 2019. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Glen Eagle Advisors held 8,272 shares of Medtronic worth $717K as of Q1 2026.
- Glen Eagle Advisors bought 432 Medtronic shares in Q1 2026, an estimated $41.4K.
- Medtronic made up 0.1% of Glen Eagle Advisors's portfolio in Q1 2026, its #136 holding.
- Glen Eagle Advisors first reported a position in Medtronic in Q4 2016 and has held it in 38 quarters since.
- Glen Eagle Advisors's Medtronic position peaked at $1.72M in Q4 2019.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.